News >

CAR T Cells Could Revolutionize RCC Treatment

Jessica Hergert
Published: Monday, Sep 23, 2019

Wayne A. Marasco, MD, PhD, professor of medicine at Harvard Medical School, and principal investigator of cancer immunology and virology at Dana-Farber Cancer Institute

Wayne A. Marasco, MD, PhD

The explosion of CAR T-cell therapy in hematologic malignancies has revolutionized treatment for select patients, but their application in solid tumors, particularly in renal cell carcinoma (RCC), still poses significant challenges, said Wayne A. Marasco, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication